Relay Therapeutics, Inc. RLAY Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s change in other liabilities?
- Relay Therapeutics, Inc. (RLAY) reported change in other liabilities of $384K in Q1 2026.
- How has Relay Therapeutics, Inc.'s change in other liabilities changed year-over-year?
- Relay Therapeutics, Inc.'s change in other liabilities increased by 224.7% year-over-year, from -$308K to $384K.
- What is the long-term trend for Relay Therapeutics, Inc.'s change in other liabilities?
- Over 3 years (2021 to 2024), Relay Therapeutics, Inc.'s change in other liabilities has grown at a -62.6% compound annual growth rate (CAGR), from $15M to $786K.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.